Skip to main content
MapleLMS Implementation
Conferences and Meetings 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III

Short name: 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III
Course start date: 11/05/2025

Sections

General
0 activities

A Systematic Literature Review of Real-World Outcomes Following Anti-Interleukin-5 and Anti-Interleukin-5 Receptor Alpha Treatment for Hypereosinophilic Syndrome: Case Reports and Cohort Studies
A Systematic Review of 72 ASH Plenary and Late Breaking Abstracts for Racial Representation: A Health Equity Call to Action
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type -I
An Evaluation of Andexanet Alfa v. Standard of Care for Reversal of Doac-Induced Intracranial Hemorrhage – a Systematic Review and Meta-Analysis
Burden of Treatment on People with Hemophilia: Global Real-World Data
Challenges in PNH and CAD Management Revealed through Educational Interventions over Three Years
Global Prevalence of Iron Deficiency Utilizing Differing Ferritin Cut-Offs - 15, 30, and 50 μg/L
Health-Related Quality of Life, Work Productivity and Activity Impairment, and Fatigue in Patients with Idiopathic or Lymphocytic Hypereosinophilic Syndrome: A Real-World Survey
Quality of Life, Physical and Mental Health of Patients with Vaccine Induced Immune Thrombotic Thrombocytopenia after Extended Followup
Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naïve Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada
Real-World Drug Adherence, Persistence, and Healthcare Resource Utilization in Patients with Paroxysmal Nocturnal Hemoglobinuria in the USA: The Advantage Study
Real-World Experience with Combination Therapy of Fostamatinib and Thrombopoetin Receptor Agonists (TPO-RAs) for Treatment of Immune Thrombocytopenia (ITP): Patient-Reported Outcomes
Real-World Experience with Emicizumab for Hemophilia a from the Physician Perspective Based on Survey Data
Role of Social Determinants of Health on Infection-Related Hospitalizations in Pediatric Hematopoietic Stem Cell Transplant Patients within the First 100 Days Post-Transplant in an Underserved State
Treatment Adherence, Satisfaction and Quality of Life of Adult Patients with Severe Haemophilia a: Results from a Real-World Survey of Physicians and Patients